Thestocktraderhubzee Posted - 9 hours ago

WATCHLIST APR 24 2024.. $YUM Citigroup Maintains Buy on Yum Brands, Lowers Price Target to $162 $DOCS Morgan Stanley Maintains Underweight on Doximity, Maintains $25 Price Target $WOLF Deutsche Bank Maintains Hold on Wolfspeed, Lowers Price Target to $30 $KLAC Citigroup Maintains Buy on KLA, Raises Price Target to $725 $SO B of A Securities Maintains Neutral on Southern, Raises Price Target to $73

DonCorleone77 Posted - 1 day ago

$DOCS Doximity checks point to 'tepid growth,' says Morgan Stanley Morgan Stanley analyst Craig Hettenbach tells investors that in conversations with ad partners the firm has "heard more negatives than positives on Doximity" and point to tepid growth for pharma digital ad spending. The firm, which adds that "all eyes" will be on FY25 guidance in the next earnings report, keeps an Underweight rating and $25 price target on Doximity shares.

Wake44 Posted - 1 day ago

$DOCS Short companies that put out lies should be stripped of trading rights!!!All the shitty companies out there and u go after a cash flow positive company makes no sense!!!

BullYa Posted - 1 day ago

$DOCS 📉$20 should be the bottom

Stan_Vick Posted - 3 days ago

✊🏽 $DOCS stockholder filed suit vs. Doximity for masking declining sales. Jehoshaphat’s disrobing report caused $DOCS to fall 4%, losing $135M in shareholder value over two days. As investor, you can join case to be notified about potential recovery => https://11thestate.com/cases/doximity-investor-suit

11thestate Posted - 5 days ago

$DOCS and execs face class action for allegedly hiding slowing sales.

AvidMarketWatcher2 Posted - 1 week ago

$DOCS hard earn money investors move away fast - another JasonG saga.

AvidMarketWatcher2 Posted - 1 week ago

$DOCS . Investors can find better intrinsic value in $TDOC 20$ spreads over 140 countries making it highly attractive LT growth proposition. Incoming TDOC anticipated trim at least 30% to boost profits is not unreasonable.

ca_rott1487 Posted - 2 weeks ago

$DOCS is under investigation for allegations of manipulating its reporting due to Jehosaphat Research's report. You can join this claim and read more about it here:https://11thestate.com/cases/doximity-investor-case

pgyletsgo Posted - 2 weeks ago

$DOCS investors should have a class action against short sellers. Then one against those attorneys. They should be made to put up a $5 million bond every 6 months. Then the company gets it fit false info. Y’all need to not automatically sell with short reports. Look how wrong they were on elf $94 to $200:

pgyletsgo Posted - 2 weeks ago

$DOCS it’s a good stock what’s with the stock chasers?

Wake44 Posted - 3 weeks ago

$DOCS This dipshit CEO needs to respond to this short hit piece...

toddk18 Posted - 3 weeks ago

$DOCS once again, this breaks $24, you’re going straight to $20…just like last time. That’s when you decide to buy but only if it holds $20. Chart is not looking good.

insiderbuyingselling Posted - 3 weeks ago

$DOCS new insider selling: 2500 shares. http://insiderbuyingselling.com/?t=DOCS

Wake44 Posted - 3 weeks ago

$DOCS U gotta love how this piece of shit comany comes out with their short a day before market correction...Markets are so corrupt!!!

Stocksrunner Posted - 3 weeks ago

$DOCS hits oversold territory! 📉🚨 As Warren Buffett says, be greedy when others are fearful! Time to watch for a potential rebound! 📈💼

DonCorleone77 Posted - 3 weeks ago

$DOCS Doximity short report concerns mostly already known, says Evercore ISI Evercore ISI says that while the Jehoshaphat Research short report on Doximity "does highlight some valid concerns," most are already known and the determination of declining growth "appears premature." The firm's main takeaway from the report is that the duration of deferred revenues is shortening. This is not a positive to overall revenue visibility, but the company is also seeing that a smaller portion of revenue is coming from deferred sales, pointing to more in-quarter business, the analyst tells investors in a research note. Evercore keeps an In Line rating on Doximity with a $30 price target.

Elliotwavedave Posted - 3 weeks ago

$DOCS fake company downgrades lol. If you can’t see how they want the littles to get out for a buyout then be done with investing.

Wake44 Posted - 3 weeks ago

$DOCS Complete fuckin joke...Who is this dipshit company...

DonCorleone77 Posted - 3 weeks ago

$DOCS Jehoshaphat jumping on DOCS :o) Doximity falls after Jehoshaphat questions sales growth in short report Jehoshaphat Research announced a short position in Doximity via a new short report posted on its website. The firm says its forensic accounting analysis and interviews with former employees show the company' business "is coming under pressure variety of fundamental issues." Jehoshaphat believes Doximity's underlying sales, contrary to the Street's expectations for double-digit growth, are declining at a 3%-6% rate. This decline "has been masked through accelerated revenue recognition," the firm contends. Shares of Doximity were down almost 3% in morning trading.

NewsByNick Posted - 3 weeks ago

$DOCS - Jehoshaphat Research is Short Doximity Inc. (DOCS)

UncleStock Posted - 03/31/24

$CCRN $MOH $DOCS $ASTH suggested for Health Care Providers - value screen: https://zpr.io/ApRQiV4Su62E

BullYa Posted - 03/27/24

$DOCS

TeresaTrades Posted - 03/25/24

Heavy options volume $AVTR $DOCS $FTI $BMBL $MKC

Jasooon Posted - 03/25/24

$HIMS, we might have to start looking at EV/EBITDA multiples for this stock now. It seems the market is starting to value them as a high growing profitable company. Let's see if we can reach multiples of $DOCS.

Wake44 Posted - 1 month ago

$DOCS Fuck u hedge fund!!

Wake44 Posted - 1 month ago

$DOCS Just ridiculous!! Up one day down the next! One hedge fund screwing everybody!!!!

UncleStock Posted - 1 month ago

$CCRN $MOH $DOCS $ASTH suggested for Health Care Providers - value screen: https://zpr.io/ApRQiV4Su62E

Carballo09 Posted - 1 month ago

$DOCS

UncleStock Posted - 1 month ago

$CCRN $MOH $DOCS $ASTH suggested for Health Care Providers - value screen: https://zpr.io/ApRQiV4Su62E